✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Addiction RiskGeneticsSubstance Use DisorderRisk AssessmentMedical Cannabis Why This MattersUnderstanding genetic predisposition to substance...
Psychological and Psychosocial Interventions for People With Schizophrenia and Co-Occurring Substance Use Disorders: A Systematic Review and Meta-Analysis.
Substance use disorder (SUD) is commonly found in individuals with schizophrenia, with a high co-occurrence rate of approximately 41.7%. Despite this high pr…
GLP-1 meds show promise for treating addiction – Futurity.org
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Addiction MedicineGlp-1 AgonistsSubstance Use DisorderPharmacotherapyReward Pathways Why This MattersGLP-1 receptor agonists like semaglutide and...
A qualitative study on cannabis use for harm reduction and pain among veterans enrolled in an SUD treatment program.
Two-thirds of adults in the United States (U.S.) find recreational and medical cannabis use acceptable. Evidence shows that cannabis use is an effective trea…
Five Distinct Patterns of Prescription Drug Misuse Sources Identified Among US Teens
Nonmedical users who obtained prescription drugs from multiple sources were more involved in substance use. In contrast, adolescent nonmedical users who used their own leftover prescriptions were less involved in substance use.
Ibogaine research pilot program one step closer to reality after committee vote – Denver7
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PsychedelicsAddiction MedicineClinical ResearchCardiac SafetySubstance Use Disorder Why This MattersColorado's ibogaine research pilot represents a...
Cannabidiol (CBD) does not reduce cocaine reward or self-administration in a mouse model of schizophrenia genetic susceptibility.
Cannabidiol (CBD) is a non-intoxicating Cannabis sativa plant compound with some preclinical studies reporting efficacy for the treatment of psychiatric diso…
Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.
Monoamine oxidase inhibitors (MAOIs) remain an important option for patients with treatment-resistant depression (TRD) and other psychiatric conditions, desp…
Associations of Cannabis and Tobacco Use with Suicide Attempt, Suicide Death, and Overdose Death Among Veterans Prescribed Opioid Analgesics.
Little is known if cannabis and tobacco use are indicators of suicide-related risks. This longitudinal study examined associations between cannabis and tobac…
`Cannabinoids and PTSD: Clinical Evidence for Co-Occurring SUD`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments, and cannabis use does not appear to undermine treatment outcomes compared to...